These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37408473)

  • 21. PrEP uptake and delivery setting preferences among clients visiting six healthcare facilities in Eswatini.
    Inghels M; Kim HY; Tanser F; Hettema A; McMahon SA; Oldenburg CE; Matse S; Kohler S; Geldsetzer P; Bärnighausen T
    AIDS Behav; 2022 Oct; 26(10):3345-3355. PubMed ID: 35429309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility and acceptability of peer-delivered HIV self-testing and PrEP for young women in Kampala, Uganda.
    Nakalega R; Mukiza N; Menge R; Kizito S; Babirye JA; Kuteesa CN; Mawanda D; Mulumba E; Nabukeera J; Ggita J; Nakanjako L; Akello C; Mirembe BG; Lukyamuzi Z; Nakaye C; Kataike H; Maena J; Etima J; Nabunya HK; Biira F; Nagawa C; Heffron R; Celum C; Gandhi M; Mujugira A
    BMC Public Health; 2023 Jun; 23(1):1163. PubMed ID: 37322510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
    Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
    J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    Baeten JM; Heffron R; Kidoguchi L; Mugo NR; Katabira E; Bukusi EA; Asiimwe S; Haberer JE; Morton J; Ngure K; Bulya N; Odoyo J; Tindimwebwa E; Hendrix C; Marzinke MA; Ware NC; Wyatt MA; Morrison S; Haugen H; Mujugira A; Donnell D; Celum C;
    PLoS Med; 2016 Aug; 13(8):e1002099. PubMed ID: 27552090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya.
    Haberer JE; Oware K; Juma L; Nyerere B; Momanyi V; Odoyo J; Garrison L; Bhagat J; Musinguzi N; Baeten JM; Siegler A; Bukusi EA
    J Int AIDS Soc; 2024 Feb; 27(2):e26217. PubMed ID: 38379132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study.
    Mayanja Y; Kamacooko O; Lunkuse JF; Muturi-Kioi V; Buzibye A; Omali D; Chinyenze K; Kuteesa M; Kaleebu P; Price MA
    J Int AIDS Soc; 2022 May; 25(5):e25909. PubMed ID: 35543110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.
    Camlin CS; Getahun M; Koss CA; Owino L; Akatukwasa C; Itiakorit H; Onyango A; Bakanoma R; Atwine F; Maeri I; Ayieko J; Atukunda M; Owaraganise A; Mwangwa F; Sang N; Kabami J; Kaplan RL; Chamie G; Petersen ML; Cohen CR; Bukusi EA; Kamya MR; Havlir DV; Charlebois ED
    AIDS Patient Care STDS; 2022 Oct; 36(10):396-404. PubMed ID: 36201226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
    Lane J; Brezak A; Patel P; Verani AR; Benech I; Katz A
    Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk-based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019.
    Kinuthia J; Dettinger JC; Stern J; Ngumbau N; Ochieng B; Gómez L; Abuna F; Watoyi S; Marwa M; Odinga D; Wagner AD; Richardson BA; Pintye J; Baeten JM; John-Stewart G
    J Int AIDS Soc; 2023 Feb; 26(2):e26061. PubMed ID: 36807505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.
    Mack N; Odhiambo J; Wong CM; Agot K
    BMC Health Serv Res; 2014 May; 14():231. PubMed ID: 24886646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study).
    Ngure K; Friedland BA; Szydlo DW; Roberts ST; Garcia M; Levy L; Akello CA; Reddy K; Palanee-Phillips T; Macdonald P; Siziba B; Soto-Torres L; Hosek S; Hillier SL; Nair G; Celum C; van der Straten A
    PLoS One; 2023; 18(6):e0287525. PubMed ID: 37352296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
    Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
    J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integration of pre-exposure prophylaxis services into public HIV care clinics in Kenya: a pragmatic stepped-wedge randomised trial.
    Irungu EM; Mugwanya KK; Mugo NR; Bukusi EA; Donnell D; Odoyo J; Wamoni E; Peacock S; Morton JF; Ngure K; Mugambi M; Mukui I; O'Malley G; Baeten JM;
    Lancet Glob Health; 2021 Dec; 9(12):e1730-e1739. PubMed ID: 34798031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The study of HIV and antenatal care integration in pregnancy in Kenya: design, methods, and baseline results of a cluster-randomized controlled trial.
    Turan JM; Steinfeld RL; Onono M; Bukusi EA; Woods M; Shade SB; Washington S; Marima R; Penner J; Ackers ML; Mbori-Ngacha D; Cohen CR
    PLoS One; 2012; 7(9):e44181. PubMed ID: 22970177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda.
    Hickey MD; Ayieko J; Owaraganise A; Sim N; Balzer LB; Kabami J; Atukunda M; Opel FJ; Wafula E; Nyabuti M; Brown L; Chamie G; Jain V; Peng J; Kwarisiima D; Camlin CS; Charlebois ED; Cohen CR; Bukusi EA; Kamya MR; Petersen ML; Havlir DV
    PLoS Med; 2021 Sep; 18(9):e1003803. PubMed ID: 34543267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Process evaluation of PrEP implementation in Kenya: adaptation of practices and contextual modifications in public HIV care clinics.
    Irungu EM; Odoyo J; Wamoni E; Bukusi EA; Mugo NR; Ngure K; Morton JF; Mugwanya KK; Baeten JM; O'Malley G;
    J Int AIDS Soc; 2021 Sep; 24(9):e25799. PubMed ID: 34496148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
    Mugambi ML; Odhiambo BO; Dollah A; Marwa MM; Nyakina J; Kinuthia J; Baeten JM; Weiner BJ; John-Stewart G; Barnabas RV; Hauber B
    J Int AIDS Soc; 2024 Jul; 27 Suppl 1(Suppl 1):e26301. PubMed ID: 38965978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya.
    Ortblad KF; Kearney JE; Mugwanya K; Irungu EM; Haberer JE; Barnabas RV; Donnell D; Mugo NR; Baeten JM; Ngure K
    Trials; 2019 Jul; 20(1):396. PubMed ID: 31272495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV risk and pre-exposure prophylaxis interest among women seeking post-abortion care in Kenya: a cross-sectional study.
    Heffron R; Casmir E; Aswani L; Ngure K; Kwach B; Ogello V; Kiptinness C; Ambiyo F; Wairimu N; Ossome E; Machafu H; Zia Y; Thomas D; Scoville C; Barker T; Bukusi E; Mugo N
    J Int AIDS Soc; 2021 May; 24(5):e25703. PubMed ID: 33973355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.